Introduction
The net gene is unique to the primate lentiviruses. Over the last 5 years it has become clear that nefplays a key role in the pathogenesis of AIDS and this has led to a resurgence in interest in the function of what was originally considered to be a 'negative factor', dispensable for virus growth, at least in vitro. This review is an attempt to summarize our current knowledge of the biochemistry and cell biology of the Net protein and to put this into the context of the requirement for net in vivo.
The open reading flame encoding the Net protein is situated at the 3' end of the viral genome, overlapping the 3"LTR (see Fig. 1 ). It is translated from a single coding exon present on a number of multiply spliced mRNA species. Netspecific mRNA has been reported to constitute up to 80 % of the viral mRNA present in infected cells at early time points after infection (Robert-Guroff et al., 1990) ; however, whether this equates to a similar preponderance of Net protein product remains to be elucidated. In human immunodeficiency virus 1 (HIV-1) the open reading flame is 618 bp, coding for a protein product of 206 amino acids, but there is a degree of length heterogeneity between isolates. HIV-2 and simian immunodeficiency virus (SIV) Net products are somewhat larger, between 250 and 265 amino acids. The primary amino acid sequence of Net is highly variable (Delassus et al., 1991; Harris et al., 1992; Shugars et al., 1993) and this variability in the primary structure of Net manifests itself in marked differences of the mobility of different Net proteins in SDS--PAGE and, more significantly, has possibly contributed to the contradictory results published about Net function over the last decade.
Structure of Nef (i) The role of rnyristoylation
Until recently, very little was known about the threedimensional structure of the Net protein. Native Net is cotranslationally modified by the addition of a myristoyl Author for correspondence: Mark Harris. Fax +44 141 330 5602. e-mail m.harris@vet.gla.ac.uk group to a conserved N-terminal glycine (Allan et al., 1985) . Myristoylation of Net has been shown to be critical for its function in a number of assay systems and is required for association of Net with cytoplasmic membrane structures, as will be discussed later in this review. However, the role of myristoylation in determining the tertiary structure of Net has not been addressed. It is conceivable that, by analogy to other myristoylated proteins such as the catalytic subunit of cAMPdependent protein kinase (Zheng et al., 1993) , the photoreceptor protein recoverin (Tanaka et al., 1995) and the MARCKS family (Aderem, 1992) , the myristoyl group of Net may play a structural role, possibly by interacting with hydrophobic regions within the protein itself. Taking these analogies further provides a plausible explanation for the observed distribution of myristoylated Net between membrane and cytosol (see section 3 below): recoverin undergoes a Ca ~+-myristoyl switch whereby the myristoyl group in the Ca 2+-free protein is sequestered within the protein but is exposed upon binding of Ca 2+, allowing interaction with the membrane (Tanaka et al., 1995) . MARCKS is released from the membrane by protein kinase C (PKC)-dependent phosphorylation, which introduces negative charge to the protein, neutralizing electrostatic interactions with acidic phospholipids (the myristoylelectrostatic switch) (Aderem, 1992) . Two conformationally distinct forms of Net might exist in which the myristoyl group is either anchored into the lipid bilayer or sequestered by hydrophobic interactions with the protein itself. This conformational switch could be generated by an additional modification such as phosphorylation or by interactions with specific cellular proteins. This hypothesis is indirectly supported by two structural studies of recombinant Net expressed in Escherichia coil Several years ago a nuclear magnetic resonance (NMR) study (Freund et at., 1994a ) revealed a two-domain structure: firstly, a compactly folded, hydrophobic core domain extending from amino acid 66 to the C terminus that was relatively resistant to proteolysis apart from a predicted loop between Glu-155 and Glu-172; and secondly, an N-terminal domain that exhibited no defined structure and was highly accessible to proteolytic cleavage, suggesting a surface location. More recently, the solution structure of a partially deleted Net protein was solved using NMR (Grzesiek et al., 1996) . Again, this study revealed a disordered N-terminal 39 amino acids and a loop between amino acids 159-173. Indeed, the investigators were only able to solve the structure by deleting these two regions. It is tempting to suggest that addition of a myristate residue would confer some structural constraints on the N-terminal domain, particularly if the myristate were embedded in a binding pocket. In passing, it is pertinent to note that recombinant Nef produced in E. coli is efficiently myristoylated in vitro by purified recombinant human N-myristoyltransferase (NMT; Jeff Mcllhinney, personal communication) suggesting that not only is the N-terminal sequence of Nef an extremely good substrate for NMT but that the N terminus of non-myristoylated Nef is exposed. Intriguingly, the boundary between the two domains identified in the earlier study coincides with both a highly conserved run of acidic residues and also a specific cleavage site for the HIV-1 protease (Freund et al., 1994 b; GaedigkNitschko et al., I995) . Cleavage of membrane-bound Nef by protease would release the C-terminal domain allowing it to relocate within the cell and could be potentially important for Nef function. However, cleavage of Nef by protease has yet to be demonstrated in vivo.
(ii) Does Nef exist in an oligomeric form?
A number of studies have suggested that Nef is able to form dimers or higher-order structures both in vitro and in vivo. Baculovirus-or E. coli-expressed HIV-I Nef formed both disulphide and non-covalently linked oligomers (Kienzle et aL, I993) . Although the cytoplasm is generally thought to be a reducing environment there is evidence that the intracellular reduced glutathione concentration of HIV-infected lymphocytes is low, conditions that might allow the formation of disulphide bridges. A proposed leucine-repeat motif in HIV-2 Nef was reported to be involved in oligomer formation in vitro (Hodge et al., 1995) , and it was suggested that disulphide bonds were important both for dimer formation and for the structure of a Nef monomer as Cys-Gly mutants disrupted dimer formation even in the absence of reducing agents.
'.38( Furthermore, they demonstrated that oligomeric forms of HIV-2 Nef could be immunoprecipitated from infected H9 cells and, interestingly, only the dimeric form was phosphorylated. We have consistently observed Nef dimers under both reducing and non-reducing conditions and also have preliminary evidence from the yeast two-hybrid system for Nef dimer formation in vivo. It is clear that the whole question of whether Nef oligomer formation is physiologically relevant or merely an artifact of experimental procedure needs to be addressed. The first step in this process must surely be the precise definition of amino acid sequences within Nef responsible for the observed oligomerization. It is still possible that disulphide bond formation might play a role in vivo; there is evidence from a number of laboratories that Nef is associated with intracytoplasmic membrane structures and indeed that Nef is secreted (Fujii el al., 1993; Otake et al., 1994) . If Nef were present within the lumen of the endoplasmic reticulum (ER) and/or Golgi apparatus it would be in a non-reducing environment; alternatively, Nef might be protected from the reducing environment within the cytoplasm by local conditions.
Subcellular localization of Nef
This discussion leads into a consideration of the subcellular localization of Nef. Nef was originally described as a cytoplasmic protein (Franchini el al., I986) and it is generally accepted that the protein is present both as a soluble component and associated with cytoplasmic membrane structures. Association with the Golgi apparatus (Ovod el al., 1992) or the nuclear membrane (Kienzle et al., 1992) has been reported. In transiently transfected Cos cells (Yu & FeMed, I992; Kaminchik el a] ., 1994), stably transfected HeLa cells and recombinant baculovirus-infected Sf9 insect cells (M. Harris, unpublished data) membrane association was absolutely dependent on myristoylation. However, studies with other myristoylated proteins, such as the Src family tyrosine kinases, have indicated that myristoylation alone is not sufficient to stably anchor a protein into the membrane (Resh, 1994) . The presence of a polybasic region that interacts with acidic phospholipids in the inner leaf of the plasma membrane (Zhou el al., 1994) , or an additional acylation event such as palmitoylation (Resh, 1994) , is required for stable interaction with the membrane. There is a concentration of basic residues near the N terminus of Nef that could function as a polybasic region, but there is no evidence for this, nor is there any evidence for additional acylation of Nef. However, it is intriguing to note that the C-terminal amino acid of Nef is a highly conserved cysteine. Although this cysteine is not part of a classical CAAX box famysylation motif it is conceivable that it might be a substrate for acylation (especially palmitoylation), given its location at the C terminus.
Nef has also been demonstrated to be present in the nucleus in chronically infected astrocytes (Kohleisen et al., 1992) , infected T lymphoid cells , B cells (Kienzle el al., 1992) and T cells (Murti et al., 1993) constitutively expressing Nef and in transiently transfected Cos cells (Yu & Felsted, 1992) . In the case of chronically infected astrocytes and transiently transfected Cos cells, only non-myristoylated Nef was localized to the nucleus, suggesting that myristoylation may in some way function to retain Nef in the cytoplasm. The role of myristoylation may not be simply to anchor Nef into cytoplasmic membranes as both myristoylated and nonmyristoylated Nef are present as cytosolic proteins. Rather, myristoylation may influence the structure of Nef as discussed in section 2(i) above, occluding a genuine or cryptic nuclear localization signal. Whether nuclear Nef has a functional role in virus replication remains to be elucidated.
4. Function of Nef: early studies suggested that Nef was a GTP-binding negative factor _ Some of the earliest assays for Nef function were driven by the observation of a limited homology between Nef and the nucleotide-binding sites of G-proteins (Samuel et al., 1987; Guy et al., i987) . Thus, it was demonstrated that E. coil-derived Nef protein could both bind and hydrolyse GTP and in addition could autophosphorylate (Guy et al., 1987) . However, since this study, five reports failing to reproduce this data have been published (Kaminchik et aL, 1990; Backer et aL, 199I; Nebreda et al., 1991; Matsuura el al., 1991; Harris et aL, 1992) . In retrospect, it seems likely that the results were due to contamination with a bacterial GTP-binding activity. The material used in the first study was resolubilized from insoluble inclusion bodies by SDS treatment and was only 70 % pure. Subsequent studies used highly purified Nef proteins with a number of different primary amino acid sequences produced either in bacteria or in recombinant baculovirus-infected insect cells. It has to be said that the homology between Nef and Gproteins is not strong: three motifs have been defined that constitute a GTP-binding site, and both the primary sequence and the spacing of these motifs are absolutely conserved in all GTP-binding proteins (Dever el al., 1987) . The first motif (GxxxxGK) has a limited match in Nef (KGGLEGL), but this does not appear to be a close enough fit to form part of a GTPbinding domain. Likewise, the homologies between Nef and the other two motifs required for GTP binding (DxxG and NKxD) are similarly weak.
Early data from a number of laboratories suggested that Nef repressed virus replication, Indeed, this is where the acronym 'Nef' arose (NEgative Factor). The majority of these studies were performed with infectious proviruses containing deletions or frameshift mutations in the Nef-coding sequence and showed that these deletions produced virus that replicated to higher levels than wild4ype virus (Fisher el al., 1986; Terwilliger el al., 1986; Luciw el a] ., 1987). Similar effects were observed following infection of Nef-expressing cell lines with Nef-deleted viruses (Cheng Mayer et aI., 1989) . It was further i!iiiiiiijiiiiiiiiiiiiiiiijiiiiiiiiiiiiii!i!i !i reported that these effects were a manifestation of the inhibition of LTR-driven transcription by Nef (Ahmad & Venkatesan, 1988; Niederman et al., 1989; Maitra et al., 1991) . These observations prompted a number of groups to publish data demonstrating that such effects could not be confirmed and indeed that Nef had no effect on virus replication in the in vitro systems used (Hammes et aI., 1989; Kim et al., 1989) . It is clear now that Nef expression is in fact critical for efficient virus replication under conditions that more closely mimic the in vivo environment of virus replication, i.e. low multiplicity infection of quiescent lymphocytes that are subsequently activated. These data will be dealt with in greater detail later in this review.
Function of Nef: a positive role in virus replication (i) CD4 down-modulation
Although the early work of Guy et al. (1987) did lead a number of groups up a blind alley, pursuing the GTP-binding activity of Nef, they may be credited with the initial observation that Nef expression leads to the down-modulation of cell-surface CD4 expression. This has now been confirmed by many groups (Garcia & Miller, 1991; Anderson et al., 1993 ; Aiken et al., 1994; Rhee & Marsh, 1994a, b; Greenway et al., 1994; Bandres et al., 1995) and appears to be a highly conserved function between diverse Nef isolates (e.g. HIV-1 laboratory strains and SIVmac239) (Foster et al., 1994; Sanfridson et al., 1994) . CD4 down-modulation has been widely accepted as a reliable indication of functionality for a particular Nef isolate but this is perhaps a rather naive assumption. Until recently, the only Nef alleles that have failed to down-modulate CD4 are non-myristoylated mutants and mutants that produce unstable or poorly expressed protein products (Mariani & Skowronski, 1993; Aiken et al., 1994) . Recently, mutations of charged residues between amino acids 155 and 175 that significantly impaired CD4 down-modulation were described (Aiken et al., 1996) . In particular, a mutation of Asp-174/175 gave rise to a protein that was completely inactive and mutations of Lys-158 and Glu-160 produced a temperature-sensitive Nef protein that was impaired at 37 °C but not at 32 °C. Interestingly, these mutations coincide with the exposed loop identified in structural studies of Nef (see section 2(i) above) suggesting that this loop might be involved in binding to CD4 (see below) or interacting with components of the mammalian endocytic pathway to induce CD4 downmodulation.
The sequences in CD4 that are responsive to Nef-mediated down-modulation have been studied in detail, but contradictions still exist in the literature. As expected, the cytoplasmic domain was shown to be critical (Garcia et al., 1993; Anderson et at., 1994a) , in particular a dileucine motif that has been identified as an endocytosis signal in a number of transmembrane glycoproteins (Letoumeur & Klausner, I992; Aiken et al., 1994) . However, there is little consensus concerning the precise sequence requirements for down-modulation: truncations of the cytoplasmic domain from the C terminus have been performed by a number of laboratories resulting in the definition of the minimal Nef-responsive domain as extending to amino acid 425 (Bandres et al., 1995 ), 424 (Anderson et al., 1994a , 418 (Salghetti et al., 1995 ) or 416 (Aiken et al., 1994 . Two of these studies (Anderson et al., 1994a; Salghetti et al., 1995) demonstrated that internal deletions either between residues 397-417 or 403-418 (including the dileucine) were unresponsive to Nef. Conflicting reports concern the requirement for the two cysteines involved in binding to p56Lck (residues 420 and 422). These residues were shown to be required for Nef responsiveness in Jurkat cells (Bandres et al., 1995) but not in NIH3T3 cells (Anderson et al., 1994a) . A further confusion arises from the fact that different groups used different nef alleles in their experiments (SF2, NL4-3 or primary isolates). The biochemical mechanism of downmodulation also remains the subject of much speculation. Although physiological down-modulation of CD4 (eg by antibody cross-linking) requires phosphorylation of serine residues in the cytoplasmic tail by PKC (in particular serines at 408 and 415), these serines were shown to be dispensable for Nef-mediated down-modulation (Garcia & Miller, 1991) . It seems likely therefore that the latter occurs by a novel mechanism. Although the rates of CD4 synthesis and transport to the plasma membrane are unaffected, Nef expression does appear to induce an increase in the rate of endocytosis of CD4 (Aiken et al., 1994; Rhee & Marsh, 1994b; Sanffidson et al., 1994) . The fate of down-modulated CD4 is also unclear. Conflicting results have been published indicating either an increase in the rate of lysosomal sorting and degradation (Aiken ef al., 1994; Rhee & Marsh, 1994b; Sanffidson et al., 1994) , or an accumulation of CD4 in early endosomes (Schwartz et al., 1995) or the Golgi apparatus (Brady et al., 1993) .
The apparent specificity and novel mechanism of CD4 down-modulation by Nef have led to the suggestion that a direct physical interaction between the two proteins might play a role in the process. Such an interaction has been detected in insect cells coinfected with recombinant baculoviruses expressing CD4 and Nef (Harris & Nell, 1994) and more recently using the yeast two-hybrid system (Rossi et al., 1996) . The sequence requirements for the interaction in insect cells mirror those necessary for down-modulation in mammalian cells, i.e. Nef myristoylation and the cytoplasmic domain of CD4 were critical. However, in the yeast two-hybrid assay Nef was not myristoylated suggesting that the role of myristoylation may simply be to target Nef to the plasma membrane for interaction with CD4, rather that playing a more direct role in the interaction.
This interaction has not been observed to date in a mammalian context, but in insect cells CD4 is not downmodulated, either by Nef or by phorbol myristate acetate (PMA), so clearly a critical component of the mammalian endocytic machinery is missing. One possible explanation for this is that glycosylation in insect cells is restricted compared to mammalian cells,as insect cells lack the enzymes required for the generation of complex glycosylation patterns (Davies, 1995) . Specific complex glycosylation events have been shown to be involved in targeting, at least in the secretory pathway (Fiedler & Simons, 1995) . For example N-glycans on lysosomal enzymes are specifically modified to generate a mannose 6-phosphate residue that is recognized by a receptor in the transGolgi that sorts proteins into the lysosomal pathway. It might therefore be the case that in baculovirus-infected insect cells heterologous glycoproteins would not be endocytosed because of the lack of specific modifications.
The observation of a direct interaction in both the baculovirus and yeast two-hybrid systems suggests that in a situation where down-modulation can occur (i.e. mammalian cells) the interaction may be transient and could serve merely to recruit CD4 into coated pits from whence endocytosis can occur. The formation of a Nef-CD4 complex might expose endocytosis signal(s) either within the cytoplasmic domain of CD4 (e.g. the dileucine motif) or within Nef. Although serine phosphorylation of CD4 is not required for Nef-mediated down-modulation, it is still conceivable that phosphorylation of Nef might play a role.
The role of Nef-mediated CD4 down-modulation in the pathogenesis of HIV infection is not clear. The first and most obvious role would be to prevent lethal superinfection. Although some in vitro evidence for this has been published for SIV (Benson et al., 1993) it would seem likely that in order to efficiently accomplish this Nef would essentially have to remove all CD4 from the cell surface. Kinetic studies clearly show that this is not the case, as Nef does not influence the rates of synthesis or transport of CD4 to the surface, merely increases the rates of endocytosis and degradation. A more plausible role, given that HIV infection results in a progressive qualitative as well as quantitative decline in the CD4 + population, would be to interfere with the function of CD4 + cells. There are two ways in which CD4 down-modulation could result in impaired function. Firstly, by inhibiting interactions between CD4 + cells and antigen-presenting cells (APCs). The interaction between the extracellular domains of CD4 and non-polymorphic regions of MHC class II molecules on APCs strengthens and stabilizes the interaction between the T cell receptor (TCR) and class II molecules. By reducing the surface CD4 concentration, Nef might prevent activation of T cells through the TCR or result in the transduction of an inappropriate signal. Secondly, it is believed that CD4 can transduce signals independently of the TCR. Down-modulation would clearly interfere with these signals and in this context there are a number of reports that CD4 can transduce signals that negatively regulate virus replication. Such an effect has been observed following incubation of infected cells with anti-CD4 antibodies that bind to the CDR3-1ike region, but not with anti-CDR2 antibodies (Benkirane et at., 1993) . In addition interleukin-16 (IL-16), one of the soluble factors secreted by CD8 + cells that has been shown to inhibit virus replication, is a natural ligand of CD4 and might therefore exert its antiviral effect through CD4 (Baser et al., 1995) .
Recently, Nef has also been shown to induce the endocytosis of MHC class I molecules both in infected U937 cells and in stably transfected T cells (Schwartz et aI., 1996) . The mechanism of this effect appears to be similar to that involved in CD4 down-modulation, in that rates of synthesis and transport through the ER and Golgi apparatus were unaffected whereas surface MHC class I molecules were rapidly endocytosed, accumulated in endosomes and degraded in lysosomes. There is little sequence homology between the cytoplasmic domains of CD4 and MHC class I heavy chain, suggesting that Nef might recognize some common structural feature. Whatever the underlying mechanism, it is clear that endocytosis of MHC class I by Nef early in infection would allow the virus to evade the cytotoxic arm of the immune response. This is an important new observation that needs to be confirmed by other laboratories as it will clearly contribute to the requirement for Nef in pathogenesis in vivo.
(ii) Enhancement of virus infectivity
Although early studies suggested that Nef had a negative influence on virus replication, it is now clear that, on the contrary, Nef acts to augment virus replication. The hypothesis that Nef was a negative factor was refuted in several distinct stages. Firstly, observations from two laboratories, published in late 1989, indicated a failure to observe any differences between the in vitro growth characteristics of isogenic Nef + and Nef-viruses (Hammes et al., 1989; Kim et al., 1989) . This was followed by two more papers that defined nef alleles isolated direct from patient material (de Ronde et al., 1992) or from a virus isolate with a short history of in vitro culture (ELI) (Zazopoulos & Haseltine, 1993 ) that could enhance virus replication in primary lymphocytes and, in the case of ELI Nef, in T cell lines. In contrast, Nef from the IIIB strain of HIV-1, which has a long history of in vitro culture, retarded replication in a T cell line.
The next stage in the development of this aspect of Nef function was the observation (again in two papers published together) in early 1994 that although Nef + and Nef-viruses replicated equally well in immortalized T cell lines, a requirement for Nef could be demonstrated following low multiplicity infection of primary quiescent PBMCs that were subsequently activated by lectin treatment (Spina et al., 1994; Miller et al., 1994) . Under these conditions, Nef + virus replicated 13-15-fold more efficiently than Nef-virus, with peak levels of p24 production between 15-20 days postinfection (p.i.). In contrast, the Neff viruses were producing barely detectable levels of p24 at 30 days p.i. Nef + virus was also more efficient at infecting prestimulated PBMCs, but in '.38! ii!gigiji ii',:i iiiii!',i j',i ji iii ii{!ii {"!iiiii!ii{i this case the difference between Nef + and Nef-viruses was not as marked. Significantly, the differential between Nef + and Nef-viruses was not observed following high multiplicity infection, suggesting that the early experiments that showed a negative or no effect of Nef were an artifact of the experimental conditions used, i.e. high multiplicity infection of immortalized cell lines. The authors argued convincingly that the conditions of low multiplicity infection of quiescent cells that they employed more closely resembled the situation in vivo. They further demonstrated that the effect of Nef was to increase the infectivity of virions: after normalization for p24 levels, virus supernatants from cells infected with Nef + viruses gave 13-17-fold more blue foci when assayed in a single-cell infection assay (HeLa-CD4-LTR-fl-gal cells) than Nef viruses (Miller et  a]., 1995) .
Within the last year some insights into the molecular mechanism of this enhancement have been published. The observation that Nef-virus could be rescued to wild-type levels of infectivity by expression of Nef in trans in the cell line producing the virus, but not in the target cell line, indicated that Nef in some way influences the production of virus particles (Miller et al., 1995) . An env-defective HIV-1 pseudotyped with amphotropic retrovirus envelope was also responsive to Nef, correlating with earlier data showing that CD4 was not required for Nef-mediated enhancement and suggesting that the Nef effect was at the level of core formation (Miller et al., 1995; Aiken & Trono, 1995) . Myristoylation of Nef was required for enhancement, suggesting that membrane association plays a critical role in the process (Chowers et al., 1994) . Levels of major viral structural proteins and viral RNA were unaffected by Nef and virus entry assays indicating that Nef-virus entered the cell normally. However, recent studies have shown that reverse transcription of Nef-viruses is impaired (Chowers et al., 1995; Aiken & Trono, I995) . The biochemical details of this role of Nef remain obscure as it is clear that it does not involve a simple lack of virion-associated reverse transcriptase activity (as judged by in vitro assays on virus supernatants) but in some way optimizes reverse transcriptase activity in infected cells, presumably in the preintegration complex (Stevenson, 1996) . One could speculate at length as to the possible mechanism behind this effect of Nef on reverse transcription, but one obvious possibility is that Nef itself is present in the virion. By virtue of myristoylation, it is likely to colocalize with Gag and Gag-Pol at the plasma membrane and could therefore be either actively or passively incorporated into virions. As yet there are no data to unambiguously prove or disprove this hypothesis. Alternatively, Nef might recruit cellular factors such as kinases to the assembling virus particle. In this regard, a proline-rich motif in Nef that is capable of interacting in vitro with the SH3 domains of various Src family tyrosine kinases, in particular Hck and Lck, has been recently identified (Saksela eta] ., 1995). Mutations within the proline-rich motif that abolished the ability to interact with SH3 domains also abolished enhancement of the virus infectivity function of Nef when engineered back into an infectious provirus Goldsmith et al., 1995) . Interestingly, this mutant retained the ability to down-modulate CD4, suggesting that these two functions of Nef are distinct. However, a mutant with the opposite phenotype has yet to be identified. Thus it is still a formal possibility that CD4 down-modulation is linked to enhancement of virus infectivity in vivo.
Nef has also been shown to be functional in enhancing both virus replication and pathogenicity of HIV-1 in a SCID-Hu mouse system (Jamieson et al., 1994; Aldrovandi & Zack, 1996) : Virus loads were 30--40-fold lower in human fetal thymus/liver implants infected with Nef-deleted viruses as compared with those infected with wild-type viruses. Additionally, Nef-deleted viruses failed to deplete CD4 + thymocytes in the implants, unlike wild-type viruses. Although the defect in virus replication could be largely overcome by increasing the inoculum, this increase did not result in wildtype pathogenicity (Aldrovandi & Zack, 1996) , suggesting that Nef may contribute to the pathogenesis of AIDS independently of its role in enhancing virus replication by contributing to the depletion of CD4 + T cells in infected individuals. Whether the cytotoxic or cytostatic effects of Nef in tissue culture observed by a number of groups [see section (iv) below] contribute to this in vivo effect remains to be determined. Further indirect evidence for the involvement of Nef in HIV-I pathogenicity in vivo comes from the observation of Nef deletions in two sets of long-term non-progressor (LTNP) patients (Kirchoff et at., 1995; Deacon et at., 1995) , suggesting that long-term non-progression may result from infection with an attenuated (Nef-deleted) HIV-1. However, another study (Huang et al., I995 a, b) failed to observe either deletions or functional defects in the Nef genes isolated from a cohort of LTNP patients. Nef-deletion is thus clearly not the sole cause of long-term non-progression, although it may contribute.
In a historical context it is interesting that the about-turn on the perceived function of HIV-1 Nef from negative to positive factor coincided with the first reports of a requirement for Nef in pathogenesis of SIV infection in vivo. In hindsight it did seem unlikely that HIV would possess a gene product whose function was to suppress virus replication and clearly as soon as it was demonstrated that SIV Nef had a fundamental role to play in vivo much effort was spent demonstrating that the same situation existed for HIV Nef. As in vivo experiments were out of the question for HIV (with the exception of the SCID-Hu mouse system) demonstration of an in vitro correlate was required. At this point it would seem appropriate to discuss the SIV Nef story in more detail.
(iii) The critical requirement for SIV Nef in virus pathogenesis
At the amino acid level SIV and HIV-I Nef share only 40% homology. In addition, SIV Nef is 50-60 amino acids longer
than HIV-I Net. Although the genes are at similar positions on the viral genome, unlike HIV-1 the SIV Net open reading flame overlaps with the 3' end of env. Therefore, it should not be taken for granted that the two proteins are functionally identical. The fact that the sequence and organization of SIV Net is closer to that of HIV-2 means that these differences are relevant in a purely human context. A number of early papers attempted to look at the function of SIV Net in vitro by performing analogous experiments to those carried out for HIV Net. Unsurprisingly, as for HIV, these yielded conflicting results: two reports that deletion of Net from an infectious provirus generated a virus with enhanced replicative potential in Cos cells (Niederman et al., 1991) or human Hut78 T-cells (Binninger el al., 1991) were contradicted by one paper indicating that deletion of Net had no effect in vitro (Unger et al., 1992) . Although all three papers used SIVmac isolates it should be noted that the studies demonstrating a negative effect of Net used SIVmac251 clones, which cause disease, whereas the third study used clone 1All, which does not cause disease in macaques. However, all these studies were superseded by the observation in 1991 that a SIVmac251 proviral clone with a large deletion in Net established an infection but failed to cause disease in macaques (Kestler et al., 1991) . Virus load in the animals infected with the Net-deleted virus was 1000-fold lower than wild-type, indicating that Net was required both for maintenance of high virus load and also for pathogenesis. Furthermore, when animals were infected with a provirus that contained a single point mutation in Net (generating a premature termination codon) they succumbed to disease with wild-type kinetics. Virus isolation revealed that the point mutation had reverted, allowing the production of full-length Net. This observation indicates that viruses expressing a fully functional net gene have a strong growth advantage in vivo. Other groups have confirmed these findings (Rud el al., 1992) , showing that, in the case of the SIV C8 virus isolate, in vivo repair of a 12 bp deletion can take place first by a duplication of an adjacent region and then progressive mutation of the duplicated sequence such that the translation product resembles the original amino acid sequence (Whatmore el al., 1995) . These results were a turning point in the history of Net research, paving the way for a resurgence of interest in agene product that until then had been considered nonessential. Interest was further fuelled by the observation that animals infected with the Net-deleted virus were resistant to subsequent challenge with wild-type virus, suggesting that a Net-deleted virus might have potential as a candidate attenuated virus vaccine (Daniel et al., 1992; Almond et al., 1995) . It is beyond the scope of this review to consider the pros and cons of such an approach except to say that, although doubts have been raised as to the safety of such a vaccine following reports of the lethality of SIV deletion mutants in neonatal macaques (Baba et al., 1995) , research continues apace.
Recently, Net from pbj14, an acutely pathogenic strain of SIV that is lethal in pig-tailed macaques within 10 days of infection, was reported to have transforming ability in NIH3T3 cells as a result of the presence of tyrosine residues at the N terminus that constituted binding sites for SH2 domains (Du el al., 1995) . Although of interest, it is far from clear whether this mutant represents an artifact that could not possibly exist in the wild, especially given the degree of adaptation of SIV to its host, or an exaggerated manifestation of the true function of Net. In addition, there is little homology between SIV and HIV-1 in this region so that this observation cannot explain the mechanism of action of HIV-1 Net.
(iv) Effects of Nef on cellular signal transduction pathways
Even before the acquisition of any functional data, a number of factors (namely the myristoylation of Net and its association with the plasma membrane and the limited sequence homology between Net and G-proteins discussed above) prompted investigators to hypothesize that Net might play a role in perturbing signal transduction pathways in the infected cell. The early observations of repression of LTR-driven transcription led to suggestions that Net might be interfering with the activation of transcription factors involved in LTR function (Ahmad & Venkatesan, 1988; Yu & Felsted, 1992; Maitra et al., 1991) . This view was supported by a number of reports of specific inhibition of the inducible transcription factors NF-~cB (Niederman et al., 1992; Bandres & Ratner, 1994) and AP-1 (Niederman et al., 1993; Bandres &Ratner, 1994) in human T cells constitutively expressing Net. This effect of Net was shown to be abolished by mutation of Ala-15 --+ Thr (Bandres et aI., 1994) , in apparent contradiction of an earlier study (Laurent et al., 1990) which had suggested that Net containing Ala-15 was inactive as it exhibited a very short half-life, was not phosphorylated and did not down-modulate CD4. Furthermore, it has been reported that stimulation of T cells expressing Net with mitogens or anti-TCR antibodies failed to elicit activation of either transcription factor whereas stimulation by lipopolysaccharide (LPS), tumour necrosis factor (TNF) or IL-1 was unaffected by Net, suggesting that Net specifically interfered with a signal emanating from the TCR (Bandres &Ratner, 1994); however, these results remain to be corroborated. Both NF-KB and AP-1 are involved in expression of IL-2 following antigenic stimulation of T cells and two groups have shown that IL-2 expression is impaired by Net (Luria el a] ., 1991; Collette et al., 1996a) . Luria el al. (1991) demonstrated that mutation of three N-terminal amino acids (Ala-15 -+ Thr, Gly-29 --* Arg and Val-33 --+ Ala) abolished this impairment. Again, this observation has been questioned (Schwartz et aI., 1992) and awaits confirmation.
In an attempt to analyse these effects of Net at the biochemical level, Net was expressed as a fusion with the extracellular and transmembrane regions of CDSe in Jurkat T cells (Baur et al., 1994) . Only a small proportion of the chimera was expressed on the cell surface, but when these cells were activated by anti-TCR antibodies the CDS-Nef chimera ~.38~ 
inhibited both tyrosine phosphorylation of cellular proteins (in particular PLCyI, TCR( and an unidentified 36 kDa protein) and calcium flux. However, when a subpopulation of cells that expressed high levels of the chimera at the surface was selected out, these ceils appeared to be constitutively activated. They expressed the activation markers CD69 and IL-2 receptor (IL-2R), had regained the induction of tyrosine phosphorylation after stimulation, and after prolonged culture most cells died as a result of apoptosis. Despite the intriguing nature of these observations there are concerns about the relevance of the CDS-Nef chimera to the true function of Nef. The cells were clearly under selection pressure to avoid expression of the chimera at the surface (as shown by the generation of premature truncations in Nef after prolonged culture and the difficulties encountered in initial selection of clones).
Other effects of Nef on signal transduction pathways have been observed. In NIH3T3 cells Nef expression was reported to inhibit the increase in cytosolic calcium mediated by inositol 1,4,5-trisphosphate (IP~) when IP 3 levels were elevated by treatment with bombesin or platelet-derived growth factor (PDGF) (De & Marsh, 1994) . The physiological significance of this observation remains to be clarified. However, in this context it is interesting to note that a number of investigators have alluded to the cytotoxic or cytostatic effects of Nef observed when attempting to generate stable cell lines constitutively expressing Nef (Murphy el al., 1993; Baur et al., 1994; RyanGraham & Peden, 1995) . This effect of Nef has recently been confirmed using two different inducible vector systems (S. J. Cooke, unpublished results). Induction of high levels of Nef expression in HeLa, Jurkat T cells and Raw264.2 murine macrophages resulted in reductions in growth potential.
Clues to the biochemistry of Nef function from the identification of cellular Nefinteracting factors
In line with the general fervour for protein-protein interactions amongst the entire biological research community, there has been an increasing number of reports that have attempted to define the biochemistry of Nef function by identifying interactions between Nef and cellular proteins (see Table 1 ). The first report of Nef-interacting proteins utilized a myristoylated Nef--GST fusion protein produced in a baculovirus system to identify a subset of proteins in Iysates from Jurkat T cells that interacted with Nef in vitro (Harris & Coates, 1993) . Interestingly, the majority of these proteins were membrane associated and failed to bind to non-myristoylated Nef-GST, suggesting that Nef might interact with a specific membrane complex. Another set of in vitro Nef-interacting proteins was observed using E. coli-expressed GST-Nef as affinity reagent (Greenway el al., 1995) . By immunoblotting, four of these proteins were identified as p56Lck, CD4, MAP kinase/erk-I and p53. It is not possible to deduce from these data which proteins are interacting specificalIy with Nef and which are pulled down by association with other proteins. More convincing evidence for a direct interaction with CD4 came from observations using recombinant baculoviruses and the yeast two-hybrid system [discussed in section 5(i) above].
The yeast two-hybrid system has been used to identify an interaction between Nef and a component of non-clathrincoated vesicles, ]/-COP (Benichou el al., 1994) . Nef and ]/-COP were also shown to interact in vitro and in HIV-l-infected cells. This interaction has also been demonstrated in vitro using immobilized myristoylated Nef-GST and a Jurkat T cell extract (Harris, 1995) . The functional significance of this interaction remains to be analysed but it is conceivable that it might play a role in the endocytosis of CD4 and MHC class I described above [section 50)]. Benichou et al. (1994) point out that//-COP, as well as being a component of the cytosol, has been found in both the Golgi and endosomes, two compartments that have been identified as sites of CD4 accumulation in Nef-expressing cells (Brady et al., 1993; Schwartz el al., 1995) . However, the mechanism by which an interaction with //-COP might contribute to the specific effects of Nef on CD4 and MHC class I surface expression is not obvious at this stage.
A significant number of Nef-binding proteins are protein kinases, both serine/threonine and tyrosine. The CDS-Nef chimera system was used to demonstrate that Nef coprecipitated with a serine/threonine kinase that phosphorylated two other Nef-binding proteins of molecular mass 62 and 72 kDa (p62 and p72) (Sawai et al., 1994) . The identity of these proteins is as yet undefined; however, the study has been extended to show that they interact with amino acid sequences in the central conserved region and also require membrane localization of Nef (Sawai et al., 1995) . Two studies have shown that, in addition to this unidentified kinase, Nef associates with, and is phosphorylated by, novel isotypes of PKC (Ca 2+-and phospholipid-independent isotypes) (Coates & Harris, 1995; Bodeus et al., 1995) . Although both these studies were performed in vitro using E. coli-expressed GST-Nef fusion proteins, the similarity between their results suggests that this is an important observation with relevance to Nef function in vivo. It should be stated that conclusive evidence for serine phosphorylation of Nef in vivo has not yet been reported, either in Nef-expressing cell lines or in infected cells. This should not be seen as definitive evidence that Nef is not phosphorylated since it is possible that Nef phosphoryiation will be transient and may require specific signals to be delivered to the cell. Resolving this issue is clearly a priority for the future.
The recognition that Nef possesses a consensus SH3-binding proline repeat motif (amino acids 69-78) that is well conserved amongst Nef isolates led to the observation that this motif was able to participate in interactions with members of the Src family of non-receptor tyrosine kinases. Using filterbinding assays and plasmon resonance it was shown that the Nef proline motif bound to the SH3 domain of Hck with high affinity (K D 250 nM for intact Nef but 300-fold weaker for the , p97, p75, p57, p55, p32, p28, p26 p70, p60, p56, p44, p36, p32, p30, p28, p27 Sawai et al. (1994) Harris & Neil (1994) Rossi et al. (1996) Harris ( Benichou et al. (1994) Harris (1995) isolated PxxP motif) Lee et al., 1995) . An additional PxxP motif at amino acids 147-150 was also implicated in the interaction, possibly explaining the decreased affinity of the isolated PxxP motif. No interactions with other SH3 domains, namely Lck and Fyn, were observed. In partial contradiction to this, a specific interaction with the SH3 domain of Lck, with no binding to Fyn, PI3K and Grb2 SH3 domains has been documented (Collette et al., 1996b) . Although these interactions were easily demonstrated using isolated protein domains it was also important to show that they could occur in the context of the native proteins. Both groups showed that this was the case: Hck could be precipitated from extracts of U937 cells by immobilized GST-Nef (but not by a proline motif mutant form) and Nef coimmunoprecipitated with Lck from Jurkat cells expressing Nef. In addition to the interaction between the Nef proline motif and the Lck SH3 domain it was reported that Nef was tyrosine phosphorylated and interacted with the Lck SH2 domain (Collette et al., 1996 b) . The site(s) of tyrosine phosphorylation have not yet been identified but it is intriguing to note that a tyrosine at position 127 is situated in a region of homology to the C-terminal regulatory tyrosine (505) of Lck (Nef, YI~7-T-P-G-P; Lck, y~05_Q_p_Q_p). The phosphorylated tyrosine in Nef could potentially compete for binding to the Lck SH2 domain.
A functional interaction between Nef and Lck could help to explain the role of Nef in AIDS pathogenesis. Lck is critically important for T cell activation and development (Anderson et al., 1994 b) and it has been well documented that Lck-deficient T cell lines are severely compromised in early events such as calcium mobilization as well as downstream events such as IL-2 production. One model for Lck function is that it phosphorylates activation motifs (ITAMs) in the cytoplasmic domain of the l-chain of an engaged TCR complex which then bind to another tyrosine kinase, ZAP-70. ZAP-70 is in turn phosphorylated and activated by Lck and proceeds to phosphorylate downstream effector molecules. By binding active Lck and inhibiting its kinase activity, Nef would effectively block this process. The inhibition of Lck function should be considered in the context of CD4 down-modulation by Nef: CD4 downmodulation results in the activation of Lck and its concomitant dissociation from CD4, thus allowing it to interact with other cellular proteins including the TCR. One plausible model for Nef function in T cells is that Nef interacts with and downmodulates CD4, thus preventing the transduction of negative signals for virus replication [see section 5(i) above]. As a result of down-modulation Lck is activated and released from CD4. Nef then interacts with activated Lck and inhibits its kinase activity, thus preventing downstream phosphorylation events which would lead to T cell activation.
Prospects for antiviral strategies targeted at Nef
The studies with SIV Nef demonstrate conclusively that Nef is of critical importance for virus replication and pathogenicity. It follows that inhibition of Nef function would be of therapeutic benefit and might even allow the development of antiviral agents that would be efficacious in the long-term, rather than the short-term benefits that are gained from presently available anti-retroviral agents such as reverse transcriptase or protease inhibitors. The reason for suggesting this is that Nef function requires specific and potentially novel interactions with cellular components, unlike reverse transcriptase and protease, which act on viral components and are largely independent of cellular factors. By developing specific inhibitors of the interactions between Nef and the cytoplasmic tail of CD4 (Harris & Nell, 1994; Rossi eta]., 1996) or the SH3 domains of the tyrosine kinases p56Lck/p59Hck (Collette et al., 1996b; Saksela et aI., 1995) the hope would be that Nef mutations that conferred resistance to these inhibitors would also be functionally compromised. Clearly, the development of such inhibitors will require a detailed structure--function analysis of Nef, enabling these interactions to be precisely defined in biochemical terms. Although such information is not yet available progress is being made: in particular, the recent publication of a solution structure of Nef determined by NMR (Grzesiek et al., 1996) will be invaluable in defining interacting domains. For example, this report shows that the two separate PxxP motifs (amino acids 69-78 and 147-150) predicted to cooperate in SH3 binding are in fact closely located in the three-dimensional structure allowing the delineation of an SH3 domain-binding surface. The novel nature of the interactions between Nef and cellular proteins may facilitate the design of inhibitors that do not interfere with normal cellular functions. Support for such a concept comes from preliminary data suggesting that the requirements for the interaction of Nef with the cytoplasmic domain of CD4 appear to be distinct from those required for interaction of p56Lck with CD4, insofar as mutations of the cysteines at residues 420/422 abolish Lck binding but have no effect on Nef binding (M. Harris, unpublished observations).
Nef is a highly immunogenic protein and HIV-infected individuals frequently exhibit strong antibody (Cheingsong Popovet al., 1990; Ranki et al., 1990) and CTL responses (Culmann et al., 1991; Hadida et al., 1992) to Nef. Evidence from macaques immunized with vaccinia virus recombinants expressing Nef suggests that Nef-specific CTLs are protective (Gallimore et al., 1995) , as an inverse correlation between the Nef-specific CTL precursor frequency and virus load was observed. Thus it seems likely that these responses could be involved in the control of infection during the clinical latency phase. Enhancing the immune response to Nef might therefore be a potential therapeutic option that should be considered, with the proviso that the primary amino acid sequence of Nef is highly variable making immune escape likely. This type of approach would therefore need to be targeted to conserved functional domains of Nef, again invoking the requirement for a detailed structure-function analysis.
Conclusions
Much progress has been made since the identification of Nef (or 3'off as it was then known) as a protein product of HIV-1 in 1985 (Allan ef al., 1985 . As I have discussed in this review, a decade of studies has shown that Nef has a number of clearly defined in vitro biological functions and a critical role in virus pathogenesis in vivo. There are several tasks to be undertaken in the foreseeable future. Firstly, the biochemical mechanisms of Nef function in vitro must be accurately defined, hopefully leading to the development of chemotherapeutic antiviral agents. Implicit in this analysis must be the investigation of the influence of Nef on virus replication in cell types other than T cells that are known to be infected by HIV, e.g. macrophages and glial cells. It is conceivable that the biochemistry of Nef function in these cell types may be distinct from that in T cells. With regard to macrophages it is pertinent that Nef apparently interacts with a macrophage-specific tyrosine kinase, Hck, with high affinity . Secondly, the relative contribution of each of the in vitro functions to the role of Nef in vivo must be identified. Intuitively, it is to be expected that both CD4 downmodulation and the enhancement of virus infectivity will be important for pathogenesis of HIV infection. However, formal proof of this must be obtained. It will also be important to ascertain whether these in vitro functions are truly independent. Although both CD4 down-modulation and enhancement of virus infectivity can occur independently under in vitro conditions, it cannot be ruled out that they are linked in some way in vivo. They may be manifestations of an underlying biochemical mechanism, as yet unidentified. The most obvious grey area concerning Nef function is the effect of Nef on signal transduction pathways. This aspect of Nef embraces the most controversy and disagreement and clear interpretation of the available data is impossible. Above all, the priority here must be to demonstrate that any effects of Nef observed in vitro are relevant to virus replication and not merely artifacts of expression of a heterologous protein. That is the real challenge for the future. 
